Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials

BACKGROUND: Detailed toxicity data are routinely collected in breast cancer (BC) clinical trials. However, ovarian toxicity is infrequently assessed, despite the adverse impacts on fertility and long-term health from treatment-induced ovarian insufficiency. OBJECTIVES: To determine the barriers to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Wanyuan, Phillips, Kelly-Anne, Francis, Prudence A., Anderson, Richard A., Partridge, Ann H., Loi, Sherene, Loibl, Sibylle, Keogh, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127191/
https://www.ncbi.nlm.nih.gov/pubmed/35597179
http://dx.doi.org/10.1016/j.breast.2022.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127191/
https://www.ncbi.nlm.nih.gov/pubmed/35597179
http://dx.doi.org/10.1016/j.breast.2022.05.002

Ejemplares similares